Literature DB >> 7538439

Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain.

T Li1, S Tsukada, A Satterthwaite, M H Havlik, H Park, K Takatsu, O N Witte.   

Abstract

Bruton's tyrosine kinase (BTK) is a nonreceptor tyrosine kinase critical for B cell development and function. Mutations in BTK result in X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Using a random mutagenesis scheme, we isolated a gain-of-function mutant called BTK* whose expression drives growth of NIH 3T3 cells in soft agar. BTK* results from a single point mutation in the pleckstrin homology (PH) domain, where a Glu is replaced by Lys at residue 41. BTK* shows an increase in phosphorylation on tyrosine residues and an increase in membrane targeting. Transforming activity requires kinase activity, a putative autophosphorylation site, and a functional PH domain. Mutation of the SH2 or SH3 domains did not affect the activity of BTK*. Expression of BTK* could also relieve IL-5 dependence of a B lineage cell line. These results show that transformation activation and regulation of BTK are critically dependent on the PH domain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538439     DOI: 10.1016/1074-7613(95)90026-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  48 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.

Authors:  S Nisitani; A B Satterthwaite; K Akashi; I L Weissman; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  The GRP1 PH domain, like the AKT1 PH domain, possesses a sentry glutamate residue essential for specific targeting to plasma membrane PI(3,4,5)P(3).

Authors:  Carissa Pilling; Kyle E Landgraf; Joseph J Falke
Journal:  Biochemistry       Date:  2011-10-19       Impact factor: 3.162

4.  Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.

Authors:  Y Kawakami; S E Hartman; E Kinoshita; H Suzuki; J Kitaura; L Yao; N Inagaki; A Franco; D Hata; M Maeda-Yamamoto; H Fukamachi; H Nagai; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.

Authors:  S Nisitani; R M Kato; D J Rawlings; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

7.  Dictyostelium PAKc is required for proper chemotaxis.

Authors:  Susan Lee; Francisco Rivero; Kyung Chan Park; Emerald Huang; Satoru Funamoto; Richard A Firtel
Journal:  Mol Biol Cell       Date:  2004-10-13       Impact factor: 4.138

8.  Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.

Authors:  G M Dingjan; A Maas; M C Nawijn; L Smit; J S Voerman; F Grosveld; R W Hendriks
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

9.  Calmodulin and PI(3,4,5)P₃ cooperatively bind to the Itk pleckstrin homology domain to promote efficient calcium signaling and IL-17A production.

Authors:  Xinxin Wang; Scott E Boyken; Jiancheng Hu; Xiaolu Xu; Ryan P Rimer; Madeline A Shea; Andrey S Shaw; Amy H Andreotti; Yina H Huang
Journal:  Sci Signal       Date:  2014-08-05       Impact factor: 8.192

10.  Molecular modeling of the membrane targeting of phospholipase C pleckstrin homology domains.

Authors:  Shaneen M Singh; Diana Murray
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.